BARRIOLIDES
Live / Registered — Registered (as of 03 Oct 2023)
What this means for you
Registered since 03 Oct 2023. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79346405
- Registration number
- 7178487
- Mark type
- Stylized text
- Filed
- 09 Jun 2022
- Published for opposition
- 18 Jul 2023
- Registered
- 03 Oct 2023
- Attorney of record
- Susan Fentress
Goods and services
- Class 001 — Chemicals: Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry, except fungicides, herbicides, insecticides and parasiticides; biological preparations for use in industry and science
- Class 005 — Pharmaceuticals: Pharmaceutical and veterinary preparations to improve function of membranes in the body; pharmaceutical and veterinary preparations to improve function of membranes in the lung; pharmaceutical and veterinary preparations to enhance the epithelial barrier; pharmaceutical and veterinary preparations to enhance the airway epithelial barrier; pharmaceutical and veterinary preparations to inhibit inflammation; pharmaceutical and veterinary preparations for the treatment of a disease or condition that is caused by a defect in epithelial cells or tissue; pharmaceutical and veterinary preparations for the treatment of a disease or condition that benefits from enhancement or restoration of epithelial barrier function; pharmaceutical and veterinary preparations for the treatment of a disease or condition of epithelial tissue in the respiratory tract; pharmaceutical and veterinary preparations for the treatment of epithelial dysfunction; pharmaceutical and veterinary preparations for the treatment of human airway epithelial cells; pharmaceutical and veterinary preparations for the treatment of chronic respiratory diseases; pharmaceutical and veterinary preparations for the treatment of viral airways diseases; pharmaceutical and veterinary preparations for the treatment of an airways disease; pharmaceutical and veterinary preparations for the treatment of asthma; pharmaceutical and veterinary preparations for the treatment of chronic obstructive pulmonary disease (COPD); pharmaceutical and veterinary preparations for the treatment of cystic fibrosis; pharmaceutical and veterinary preparations for the treatment of non-cystic fibrosis bronchiectasis; pharmaceutical and veterinary preparations for the treatment of chronic rhinosinusitis; pharmaceutical and veterinary preparations for the treatment of diffuse panbronchiolitis (DPB); pharmaceutical and veterinary preparations for the treatment of chronic bronchitis; pharmaceutical and veterinary preparations for the treatment of bronchiolitis obliterans organizing pneumonia (BOOP); pharmaceutical and veterinary preparations for the treatment of infantile respiratory distress syndrome (IRDS); pharmaceutical and veterinary preparations for the treatment of bronchopulmonary dysplasia; pharmaceutical and veterinary preparations for the treatment of neuromuscular respiratory depression or failure; pharmaceutical and veterinary preparations for the treatment of pneumonia; pharmaceutical and veterinary preparations for the treatment of conditions caused by and associated with respiratory syncytial virus (RSV) and related viruses; pharmaceutical and veterinary preparations for the treatment of a disease or condition commonly associated with inflammation that benefits from enhancement or restoration of epithelial barrier function; pharmaceutical and veterinary preparations for the treatment of systemic inflammatory distress syndrome (SIRS); pharmaceutical and veterinary preparations for the treatment of adult respiratory distress syndrome (ARDS); pharmaceutical and veterinary preparations for the treatment of inflammatory bowel disease; pharmaceutical and veterinary preparations for the treatment of ulcerative colitis; pharmaceutical and veterinary preparations for the treatment of Crohn's disease; sanitary preparations for medical purposes; dietary supplements for human beings and animals
- Class 042 — Scientific and technological services: Scientific and technological services and research and design relating thereto, namely, scientific research in the field of pharmaceutical studies research, scientific research in new pharmaceutical design services, medical and pharmacological research services, drug discovery services, pharmaceutical drug development services, pharmaceutical research and development; industrial analysis and research services, namely, pharmaceutical analysis and pharmaceutical research
Owner
Prosecution history
- 30 Jan 2024 — FINAL DECISION TRANSACTION PROCESSED BY IB
- 08 Jan 2024 — FINAL DISPOSITION NOTICE SENT TO IB
- 08 Jan 2024 — FINAL DISPOSITION PROCESSED
- 03 Jan 2024 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
- 03 Oct 2023 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 03 Oct 2023 — REGISTERED-PRINCIPAL REGISTER
- 18 Jul 2023 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 18 Jul 2023 — PUBLISHED FOR OPPOSITION
- 28 Jun 2023 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 18 Jun 2023 — REFUSAL PROCESSED BY IB
- 15 Jun 2023 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 14 Jun 2023 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 14 Jun 2023 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 14 Jun 2023 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 14 Jun 2023 — TEAS CHANGE OF CORRESPONDENCE RECEIVED